39 results
10-Q
2024 Q1
EX-10.3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
as if Executive were an active employee unless doing so violates applicable law or is inconsistent with the coverage arrangement.
Suspension … “Client” shall mean any Client of the Company: (1) to whom the Company or any officer, director, member, employee, contractor, affiliate
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
or indirectly, hire, engage or employ (as an employee, consultant or otherwise) any of our employees; provided that Chromocell Holdings shall … of our employees and us, for the purpose of employing or engaging the services of such employee or soliciting such employee to become an employee
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
or indirectly, hire, engage or employ (as an employee, consultant or otherwise) any of our employees; provided that Chromocell Holdings shall … of our employees and us, for the purpose of employing or engaging the services of such employee or soliciting such employee to become an employee
10-K
2023 FY
EX-97.1
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
individuals. Subject to any limitation under applicable law, the Compensation Committee may authorize and empower any officer or employee of the Company … with respect to any recovery under this Policy involving such officer or employee).
Covered Executives
This Policy applies to the Company’s current
10-K
2023 FY
EX-4.2
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans … in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender
10-K
EX-19.1
mi5 odtcc8g48
16 Apr 24
Annual report
4:48pm
10-K
8tu51 t3txw2
16 Apr 24
Annual report
4:48pm
S-8
kdl5 3to1cu
12 Apr 24
Registration of securities for employees
7:22pm
8-K
EX-1.1
a05qvc3gyyq486 5y
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-3.2
hpjpgux
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-3.1
hxig8offr j5
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
hhm78j4aow6u3
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
ta6jjf7
20 Feb 24
Prospectus supplement with pricing info
5:28pm